Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Strep A Translation

The Strep A Translation team aim to understand the epidemiology of Strep A infections in Australia and the world. Alongside this, they explore the implementation of endgame recommendations, health economics and new horizons.

The Strep A Translation team aim to understand the epidemiology of Strep A infections in Australia and the world.

The epidemiology of Strep A infections in Australia and globally remains a high priority across the END RHD program, and the work undertaken by this team intersect with the other four teams within the END RHD program.

In addition, this team research and outputs are vital for implementation of the endgame recommendations, health economics findings and most importantly new horizons for international collaborations and partnerships; such as REACH - a technical support and policy translation initiative to amplify rheumatic heart disease control efforts locally, regionally and globally.

REACH is a core partner of RHD Action, a coalition of global organisations working together to establish a scientific and technical support community available to all countries, advocate for policy change for better heart health, support and empower all people living with RHD and foster multi-sectoral partnerships to support and sustain the global movement.

This map showcases our global partnerships, linking Australia with collaborators around the world who are working together to eliminate Strep A infections, and Rheumatic Heart Disease (RHD). Each connection represents a shared commitment to community-led research, cultural respect, and meaningful action.

From locally driven programs to international research collaborations, these connections highlight our collective commitment to equity in health and ending RHD worldwide.

Strep A Translation Global Collaboration Map

 

Collaborators

Associate Professor Hannah Moore; Dr Belaynew Taye

Team leader

Professor Jonathan Carapetis AM
Professor Jonathan Carapetis AM

AM MBBS FRACP FAFPHM PhD FAHMS

Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH

Associate Professor Glenn Pearson
Associate Professor Glenn Pearson

BA (Education) PhD Candidate

Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research

Team members (14)

Program Manager END RHD

Jeffrey Cannon
Jeffrey Cannon

BSc(Hons) BBus PhD

Rosemary Wyber
Rosemary Wyber

MBChB MPH FRACGP PhD

Senior Research Fellow

Senior Research Fellow

Razieh Ahmady
Razieh Ahmady

Pharm.D, PhD

Senior Research Officer

Senior Project Coordinator

Program Coordinator

PhD Candidate and Research Assistant

Strep A Translation projects

Show more projects

Featured projects

Pacific Rheumatic Heart Disease (RHD) Program

The goal of the program is to establish the foundations of an effective, sustainable and equitable response to RHD in the Pacific.

Acute Rheumatic Fever Diagnosis Collaborative Network (ARC)

ARC is a global network of collaborators committed to reducing the burden of RHD in our lifetime.

Strep A Translation

Additional information

Reports and Findings

Show all

Antibiotic treatment duration for bloodstream infections in critically ill children - A survey of pediatric infectious diseases and critical care clinicians for clinical equipoise

To describe antibiotic treatment durations that pediatric infectious diseases (ID) and critical care clinicians usually recommend for bloodstream infections in critically ill children.

Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint

Peri-prosthetic joint infection (PJI) is a devastating complication of joint replacement surgery. Determining the optimal duration of intravenous (IV) antibiotics for PJI managed with debridement and implant retention (DAIR) is a research priority.

Rheumatic Heart Disease Control Programs, Registers, and Access to Care

Rheumatic heart disease (RHD) control programs have been recommended by the World Health Organization as the mainstay of reducing the burden of RHD for nearly half a century. Programs should be structured around a disease register of people living with RHD and to support delivery of secondary prophylaxis.

Rheumatic Heart Disease in Pregnancy: New Strategies for an Old Disease?

RHD in pregnancy (RHD-P) is associated with an increased burden of maternal and perinatal morbidity and mortality. A sequellae of rheumatic fever resulting in heart valve damage if untreated, RHD is twice as common in women. In providing an historical overview, this commentary provides context for prevention and treatment in the 21 st century. Four underlying themes inform much of the literature on RHD-P: its association with inequities; often-complex care requirements; demands for integrated care models, and a life-course approach.

Show all